Tatsis Ourania Insider Trades

Insider Trading History

Track insider trading activity for Tatsis Ourania. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $21.6M 45,321 shares
Last Trade
Jul 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$787k 1,500 shares
$524.99
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $22.3M 46,763 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$126k 260 shares
$486.35
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $22.4M 47,023 shares
Last Trade
Feb 24, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$789k 1,627 shares
$485.11
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $23.2M 48,650 shares
Last Trade
Feb 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$174k 368 shares
$473.68
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $23.4M 49,018 shares
Last Trade
Feb 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$298k 609 shares
$489.46
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $23.7M 49,627 shares
Last Trade
Feb 17, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.11M 2,294 shares
$483.75
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $24.8M 51,921 shares
Last Trade
Feb 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.76M 5,789 shares
$477.40
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $22.7M 47,632 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.86M 3,804 shares
$487.76
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $22M 46,132 shares
Last Trade
Feb 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$750k 1,500 shares
$499.99
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $24.5M 51,436 shares
Last Trade
Feb 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$215k 466 shares
$460.43
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $24.8M 51,902 shares
Last Trade
Feb 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1M 2,140 shares
$468.41
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $25.8M 54,042 shares
Last Trade
Jan 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.49M 11,749 shares
$467.35
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $20.2M 42,293 shares
Last Trade
Jan 07, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.14M 4,500 shares
$474.99
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $22.3M 46,793 shares
Last Trade
Dec 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.02M 4,500 shares
$449.99
$477.08
Verve Therapeutics
Verve Therapeutics VERV
Director
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.45M 309,741 shares
$11.13
$11.13
Verve Therapeutics
Verve Therapeutics VERV
Director
Holding Value $470k 42,200 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$242k 42,200 shares
$5.73
$11.13
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $24.4M 51,239 shares
Last Trade
Mar 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.62M 3,242 shares
$499.99
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $26M 54,481 shares
Last Trade
Mar 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.97M 4,058 shares
$485.49
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $27.9M 58,539 shares
Last Trade
Feb 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$252k 530 shares
$475.34
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Reg. & Quality Off.
Holding Value $28.2M 59,069 shares
Last Trade
Feb 26, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.38M 4,962 shares
$479.61
$477.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up